Torben F. Ørntoft

4.9k total citations · 2 hit papers
20 papers, 3.6k citations indexed

About

Torben F. Ørntoft is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Torben F. Ørntoft has authored 20 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Torben F. Ørntoft's work include DNA Repair Mechanisms (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Torben F. Ørntoft is often cited by papers focused on DNA Repair Mechanisms (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Torben F. Ørntoft collaborates with scholars based in Denmark, United States and France. Torben F. Ørntoft's co-authors include Maxwell Sehested, Frederic Tort, Jiřina Bártková, Jiří Bártek, Karsten Zieger, Claudia Lukas, Per Guldberg, Jahn M. Nesland, Zuzana Hořejšı́ and Alwin Krämer and has published in prestigious journals such as Nature, New England Journal of Medicine and Cancer Research.

In The Last Decade

Torben F. Ørntoft

20 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

2005 2.1k citations Jiřina Bártková, Zuzana Hořejšı́ et al. Nature profile →
Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations inMYH

2003 596 citations Oliver M. Sieber, Lara Lipton et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Torben F. Ørntoft Denmark	13	2.5k	1.5k	741	702	504	20	3.6k
Qingyun Liu China	18	2.1k 0.8×	1.7k 1.2×	996 1.3×	333 0.5×	291 0.6×	31	3.4k
John F. Lyons United States	32	2.7k 1.1×	1.3k 0.9×	551 0.7×	385 0.5×	251 0.5×	81	4.3k
A K Virmani United States	20	3.3k 1.3×	1.1k 0.7×	924 1.2×	406 0.6×	518 1.0×	25	4.3k
Clara Francı́ Spain	19	3.5k 1.4×	2.2k 1.4×	866 1.2×	278 0.4×	331 0.7×	25	4.7k
Irma M. Oving Netherlands	11	2.4k 1.0×	1.5k 1.0×	631 0.9×	483 0.7×	263 0.5×	21	3.6k
Brian C. Lewis United States	33	3.2k 1.3×	1.2k 0.8×	1.3k 1.8×	344 0.5×	246 0.5×	53	4.4k
Kim L. Mercer United States	10	2.6k 1.0×	1.6k 1.1×	737 1.0×	222 0.3×	350 0.7×	15	3.9k
Karsten Zieger Denmark	14	2.4k 1.0×	1.1k 0.7×	788 1.1×	170 0.2×	682 1.4×	22	3.2k
Young Kyung Bae South Korea	26	1.1k 0.4×	944 0.6×	691 0.9×	384 0.5×	331 0.7×	122	2.5k
Lora H. Ellenson United States	34	3.0k 1.2×	1.2k 0.8×	1.1k 1.5×	1.0k 1.4×	319 0.6×	108	5.5k

Countries citing papers authored by Torben F. Ørntoft

Since Specialization

Citations

This map shows the geographic impact of Torben F. Ørntoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torben F. Ørntoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torben F. Ørntoft more than expected).

Fields of papers citing papers by Torben F. Ørntoft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torben F. Ørntoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torben F. Ørntoft. The network helps show where Torben F. Ørntoft may publish in the future.

Co-authorship network of co-authors of Torben F. Ørntoft

This figure shows the co-authorship network connecting the top 25 collaborators of Torben F. Ørntoft. A scholar is included among the top collaborators of Torben F. Ørntoft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torben F. Ørntoft. Torben F. Ørntoft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mogilevsky, Maxim, Asaf Shilo, Regina Golan‐Gerstl, et al.. (2014). Mnk2 Alternative Splicing Modulates the p38-MAPK Pathway and Impacts Ras-Induced Transformation. Cell Reports. 7(2). 501–513. 93 indexed citations

Laurberg, Jens R., Anne Sofie Brems-Eskildsen, Iver Nordentoft, et al.. (2012). Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancer. British Journal of Urology. 110(11c). E1228–36. 76 indexed citations

Ostenfeld, Marie S., Dennis K. Jeppesen, Jens Preben Morth, et al.. (2012). Abstract 3387: Secreted exosomes from cultured bladder cells are enriched for distinct miRNAs detected in circulation of metastatic bladder cancer patients. Cancer Research. 72(8_Supplement). 3387–3387. 1 indexed citations

Reinert, Thomas, Charlotte Modin, Philippe Lamy, et al.. (2011). Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers. Clinical Cancer Research. 17(17). 5582–5592. 169 indexed citations

Hollegaard, Mads V., Jakob Grove, Jonas Bybjerg‐Grauholm, et al.. (2011). Robustness of genome-wide scanning using archived dried blood spot samples as a DNA source. BMC Genetics. 12(1). 58–58. 52 indexed citations

Dyrskjøt, Lars, Karsten Zieger, Francisco X. Real, et al.. (2007). Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study. Clinical Cancer Research. 13(12). 3545–3551. 154 indexed citations

Tort, Frederic, et al.. (2006). Retinoblastoma Pathway Defects Show Differential Ability to Activate the Constitutive DNA Damage Response in Human Tumorigenesis. Cancer Research. 66(21). 10258–10263. 55 indexed citations

Bártková, Jiřina, Zuzana Hořejšı́, Karen Koed, et al.. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 434(7035). 864–870. 2117 indexed citations breakdown →

Sieber, Oliver M., Lara Lipton, Michael Crabtree, et al.. (2003). Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations inMYH. New England Journal of Medicine. 348(9). 791–799. 596 indexed citations breakdown →

10.

Jagmohan–Changur, Shantie, Virpi Launonen, Friedrik P. Wikman, et al.. (2003). EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer.. PubMed. 63(1). 154–8. 50 indexed citations

11.

Lu, Ming-Lan, Friedrik P. Wikman, Torben F. Ørntoft, et al.. (2002). Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods.. PubMed. 8(1). 171–9. 116 indexed citations

12.

Pedersen, Mikkel W., Thomas Thykjær, Torben F. Ørntoft, Lars Damstrup, & Hans Skovgaard Poulsen. (2001). Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line. British Journal of Cancer. 85(8). 1211–1218. 18 indexed citations

13.

Wikman, Friedrik P., Niels Katballe, Mariann Christensen, Søren Laurberg, & Torben F. Ørntoft. (2000). Efficient Mutation Detection in Mismatch Repair Genes Using a Combination of Single-Strand Conformational Polymorphism and Heteroduplex Analysis at a Controlled Temperature. Genetic Testing. 4(1). 15–21. 8 indexed citations

14.

Ørntoft, Torben F. & Else Marie Vestergaard. (1999). Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis. 20(2). 362–371. 9 indexed citations

15.

Bech, Einar, Henning Andersen, Torben F. Ørntoft, & Johannes Jakobsen. (1998). Association of IgM type anti‐GM1 antibodies and muscle strength in chronic acquired demylelinating polyneuropathy. Annals of Neurology. 43(1). 72–78. 62 indexed citations

16.

Mayer, M., Ian Wilkinson, Risto Heikkinen, Torben F. Ørntoft, & Erik Magid. (1998). Improved Laboratory Test Selection and Enhanced Perception of Test Results as Tools for Cost-Effective Medicine. Clinical Chemistry and Laboratory Medicine (CCLM). 36(9). 683–690. 17 indexed citations

17.

Ørntoft, Torben F., et al.. (1997). A two-site lectinoenzymatic assay for determination of tumour marker glycoproteins in rectal secretions. Glycoconjugate Journal. 14(2). 191–199. 3 indexed citations

18.

Juhl, Claus Orloff, Lars Vinter‐Jensen, Steen Seier Poulsen, Torben F. Ørntoft, & Esam Z. Dajani. (1995). Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats. Digestive Diseases and Sciences. 40(12). 2717–2723. 10 indexed citations

19.

Ørntoft, Torben F. & Niels Clausen. (1994). Hereditary spherocytosis: Diagnostic and anaemia-associated aberrations of ghost proteins. Scandinavian Journal of Clinical and Laboratory Investigation. 54(2). 95–103. 5 indexed citations

20.

Jensen, Poul Henning, et al.. (1992). Characterization of carbohydrates in the α₂‐macroglobulin receptor. FEBS Letters. 305(2). 129–132. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact